4//SEC Filing
Shannon James Samuel 4
Accession 0001209191-23-051231
CIK 0001492426other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 7:25 PM ET
Size
7.7 KB
Accession
0001209191-23-051231
Insider Transaction Report
Form 4
Shannon James Samuel
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2023-09-29−11,850→ 8,150 totalExercise: $12.19Exp: 2027-08-01→ Ordinary Shares (11,850 underlying) - Exercise/Conversion
Ordinary Shares
2023-09-29$12.19/sh+11,850$144,452→ 33,156 total
Holdings
- 23,638(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]The stock option is fully vested.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001485417
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 7:25 PM ET
- Size
- 7.7 KB